First Time Loading...

ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 2.04 USD 6.81%
Updated: May 15, 2024

ATAI Life Sciences NV
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Cash from Operating Activities Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Cash from Operating Activities
-$84.1m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash from Operating Activities
€5.1B
CAGR 3-Years
1%
CAGR 5-Years
-8%
CAGR 10-Years
0%
Merck KGaA
XETRA:MRK
Cash from Operating Activities
€3.8B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
5%
MPH Health Care AG
XETRA:93M1
Cash from Operating Activities
€12m
CAGR 3-Years
56%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Cash from Operating Activities
€218.6m
CAGR 3-Years
18%
CAGR 5-Years
7%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Cash from Operating Activities
€24.7m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Cash from Operating Activities?
Cash from Operating Activities
-84.1m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Cash from Operating Activities amounts to -84.1m USD.

What is ATAI Life Sciences NV's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-59%

Over the last year, the Cash from Operating Activities growth was 19%. The average annual Cash from Operating Activities growth rates for ATAI Life Sciences NV have been -59% over the past three years .